|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.56 USD | -1.55% |
|
+4.46% | +48.54% |
| 16/07 | Insmed Insider Sold Shares Worth $699,220, According to a Recent SEC Filing | MT |
| 10/07 | Insmed Insider Sold Shares Worth $5,537,460, According to a Recent SEC Filing | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Development and Commercialization of Therapies for Patients with Rare Diseases | 16Cr | 19Cr | 25Cr | 31Cr | 36Cr | |||||
Total Assets | 80Cr | 124.35Cr | 165.64Cr | 132.98Cr | 202.52Cr | |||||
Interest Expense | -2.96Cr | -4.05Cr | -2.64Cr | -8.14Cr | -8.51Cr | |||||
Income Tax Expense | 14.02L | -17.58L | 13.83L | 25.55L | 37.07L | |||||
CAPEX | -68.22L | -72.89L | -98.78L | -1.33Cr | -2.19Cr | |||||
EBT | -29Cr | -44Cr | -48Cr | -75Cr | -91Cr | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | 1.04Cr | 1.04Cr | 74.4L | 84.41L | 88.75L | |||||
Operating Income | -27Cr | -38Cr | -46Cr | -71Cr | -88Cr | |||||
Net Income | -29Cr | -43Cr | -48Cr | -75Cr | -91Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
US | - | 16Cr | 19Cr | 22Cr | 25Cr | |||||
Japan | - | 1.6Cr | 5.65Cr | 6.57Cr | 8.77Cr | |||||
Europe and Rest of World | - | 1.29Cr | 28.58L | 1.53Cr | 2.12Cr |
- Stock Market
- Equities
- INSM Stock
- Financials Insmed Incorporated
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition